Promentis Pharmaceuticals, Inc. is developing novel compounds for the treatment of various central nervous system (CNS) disorders.
SEEKING TO REDEFINE WHAT IS POSSIBLE®
Our drug development efforts are focused on activating a unique target known to restore glutamatergic neurotransmission and imbalances in oxidative stress. We are advancing quickly into clinical trials with a keen focus on making a meaningful impact in the lives of patients and their families.
World Class Leadership and Ideas
Pioneering the discovery & development of therapeutics targeting glutamatergic imbalances and oxidative stress